Gyros Protein Technologies has introduced a new 5 CD model, Gyrolab® xPand, in response to customer requests to provide higher throughput, greater flexibility and faster analysis of large sample numbers.    The company says Gyrolab technology significantly accelerates the process of discovering and developing new and safer biotherapeutics. The technology includes optimized, ready-to-use kits for cell line development, bioprocessing applications and pre-clinical PK/TK, simplifying assay w...